These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3787007)

  • 1. [Acute and long-term effects of placebo and molsidomine on pulmonary artery pressure and on workload in patients with coronary heart disease].
    Jansen W; Osterspey A; Schell U; Tauchert M
    Schweiz Rundsch Med Prax; 1986 Oct; 75(41):1210-4. PubMed ID: 3787007
    [No Abstract]   [Full Text] [Related]  

  • 2. [Molsidomine in rest and exercise conditions in coronary heart disease. Acute and long-term effects].
    Jansen W; Meyer L; Osterspey A; Eggeling T; Tauchert M; Hilger HH
    Med Klin (Munich); 1986 Jun; 81(14):489-95. PubMed ID: 3097469
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute and chronic effects of molsidomine on pulmonary artery pressure and work capacity in patients with coronary heart disease.
    Jansen W; Eggeling T; Meyer L; Tauchert M; Hilger HH
    Eur Heart J; 1987 Aug; 8(8):870-7. PubMed ID: 3665944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term antihypertensive effect of delayed-action molsidomine].
    Fach WA; Kostanecka T; Kober G
    Z Kardiol; 1994 Sep; 83(9):646-51. PubMed ID: 7801667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cross double-blind study with verapamil x placebo in ischemic heart disease with an ergometric test].
    Ribeiro JM; Sadi J; Barros FA
    Arq Bras Cardiol; 1984 Aug; 43(2):139-42. PubMed ID: 6398044
    [No Abstract]   [Full Text] [Related]  

  • 6. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of buccal nitroglycerin on pulmonary artery pressure at rest and during exercise: a comparison with sublingual nitroglycerin in patients with coronary artery disease.
    Langbehn AF; Sheikhzadeh A; Stierle U; Thoran P
    Z Kardiol; 1983; 72 Suppl 3():239-45. PubMed ID: 6421010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects of molsidomine on weight sustaining isometric exercise in patients with ischemic heart disease.
    Tsujibayashi T; Niwa A; Taniguchi K; Takeuchi J
    Bull Tokyo Med Dent Univ; 1985 Dec; 32(4):163-7. PubMed ID: 3865742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The importance of Lopion (molsidomine) in the therapy of myocardial ischemia and angina pectoris].
    Trifunović S; Pavlović K
    Med Pregl; 1987; 40(1-2):17-21. PubMed ID: 3657717
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment].
    Zygelman M; Neukirch F; Mérillon JP; Dahan M; Trouillet JL; Juliard JM; Pansard Y; Gourgon R
    Arch Mal Coeur Vaiss; 1984 Nov; 77(12):1383-9. PubMed ID: 6150693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hemodynamic effect of molsidomine in coronary patients with heart failure with clinically manifest nitrate tolerance].
    Störk T; Möckel M; Störk S; Piske G; Danne O; Bodemann T; Müller R; Eichstädt H; Hochrein H
    Z Kardiol; 1993 May; 82(5):293-301. PubMed ID: 8328179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term molsidomine treatment versus isosorbide dinitrate and placebo on exercise tolerance in stable angina.
    Romano M; de Caprio L; Meccariello P; Cuomo S; Baldini F; D'Ascia C; Steinberg G; Chiariello M
    Int J Clin Pharmacol Ther Toxicol; 1984 May; 22(5):246-9. PubMed ID: 6430811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effectiveness of molsidomine in patients with exercise-induced angina pectoris].
    Sinkiewicz W; Dziedziczko A
    Pol Tyg Lek; 1993 Jan 18-25; 48(3-4):80-2. PubMed ID: 8361895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.
    Messin R; Opolski G; Fenyvesi T; Carreer-Bruhwyler F; Dubois C; Famaey JP; Géczy J
    Int J Cardiol; 2005 Jan; 98(1):79-89. PubMed ID: 15676171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of chewable isosorbide dinitrate in coronary insufficiency. A report on exercise electrocardiograms in 13 patients.
    Gorman PA; Evans JM
    Med Ann Dist Columbia; 1971 Apr; 40(4):235-8. PubMed ID: 4995127
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition with spirapril in patients with coronary artery disease.
    Thürmann P; Rietbrock N
    Blood Press Suppl; 1994; 2():73-6. PubMed ID: 8061851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of thrombocyte function in coronary heart disease. Results with molsidomine (Corvaton)].
    Z Kardiol; 1991; 80 Suppl 5():1-70. PubMed ID: 1776328
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
    Pornin M; Harpey C; Allal J; Sellier P; Ourbak P
    Clin Trials Metaanal; 1994 Apr; 29(1):49-56. PubMed ID: 10150185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term treatment of patients with coronary heart disease using isosorbide dinitrate, nifedipine and molsidomine.
    Jansen W; Tauchert M; Osterspey A; Hombach V; Fuchs M; Hilger HH
    Z Kardiol; 1983; 72 Suppl 3():203-10. PubMed ID: 6689389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.